Key Developments: Ambu A/S (AMBUb.CO)

AMBUb.CO on Copenhagen Stock Exchange

171.50DKK
3 Jul 2015
Change (% chg)

kr.-3.50 (-2.00%)
Prev Close
kr.175.00
Open
kr.174.00
Day's High
kr.176.00
Day's Low
kr.171.50
Volume
23,294
Avg. Vol
53,021
52-wk High
kr.200.00
52-wk Low
kr.90.50

Search Stocks

Latest Key Developments (Source: Significant Developments)

Ambu adjusts FY 2014/15 outlook
Wednesday, 6 May 2015 02:29am EDT 

Ambu A/S:Outlook for FY 2014/15 is adjusted.Says outlook is now of growth in local currencies of about 8-8.5 pct as opposed to 7-8 pct.Sees EBIT margin of about 12 pct as opposed to 12.5 pct.  Full Article

Ambu adjusts FY 2014/2015 revenue and EBIT margin guidance
Monday, 2 Feb 2015 02:29am EST 

Ambu A/S:Outlook for FY 2014/2015 relating to revenue and EBIT margin has been adjusted to revenue growth of about 16 pct from 10 pct and an EBIT margin of about 12.5 pct (12.5-13 pct).Growth in local currencies is maintained as previously announced.  Full Article

Ambu issues FY 2014/2015 guidance; proposes dividend of DKK 3.75/share for FY 2013/2014
Thursday, 13 Nov 2014 02:29am EST 

Ambu A/S:Sees 2014/2015 EBIT margin in the region of 12.5-13 pct, at unchanged exchange rates corresponding to about 13.5-14 pct.Sees 2014/2015 free cash flows of about 130-140 million crowns.Proposes dividend of 3.75 crowns per share to be declared for FY 2013/2014.Paid dividend of 1.25 crown per share for FY 2012/2013.  Full Article

Ambu A/S maintains FY 2014 guidance
Wednesday, 20 Aug 2014 02:28am EDT 

Ambu A/S:Says still expects to report revenue for the fiscal year 2013/2014 in the region of 1.6 billion Danish crowns, organic growth of about 5-7 percent and an EBIT margin of about 12-14 percent.Fiscal year 2013/2014 revenue of 1.622 billion - Thomson Reuters I/B/E/S.  Full Article

Ambu A/S maintains FY 2014 financial guidance
Friday, 2 May 2014 02:29am EDT 

Ambu A/S:Says its outlook for FY 2014 is unchanged.Sees FY 2014 revenue of about 1.6 bln Danish crowns, organic growth of between about 5 pct and 7 pct and an EBIT margin of between about 12 pct and 14 pct.Says FY 2014 free cash flows before acquisitions, milestone payments and earn-outs are expected to be between about 100 mln crowns and 120 mln crowns, with an NIBD/EBITDA ratio of about 2.5.FY 2014 revenue of 1,606.50 Danish crowns - Thomson Reuters I/B/E/S.  Full Article

Ambu acquires product from Israeli manufacturer
Thursday, 20 Mar 2014 03:24am EDT 

Ambu A/S:Acquires all rights from an Israeli manufacturer to a number of solutions within single use pain pumps for the growing American hospital market.Says it has signed an agreement with Medical Flow Systems Ltd. (MFS) in Israel for acquisition of patents and manufacturing rights behind the design of pain pump technology of which it has been distributor in the US since 2010.Says the agreement implies that Ambu takes over the ownership of patents and manufacturing know-how.Says the agreement with MFS entails that Ambu will pay $ 2 million when signing the agreement and subsequently $ 8 million in royalties and milestone payments for a period of up to seven years.  Full Article

Ambu A/S confirms FY 2013/2014 guidance
Tuesday, 4 Feb 2014 02:28am EST 

Ambu A/S:Says still expects to report revenue for the fiscal year 2013/2014 in the region of 1.6 billion Danish crowns, organic growth of approximately 5-7 percent and an EBIT margin of approximately 12-14 percent.Fiscal year 2013/2014 revenue of 1.622 billion - Thomson Reuters I/B/E/S.  Full Article

Ambu A/S Proposes FY 2012/2013 Dividend of DKK 1.25 per Share
Wednesday, 20 Nov 2013 04:51am EST 

Ambu A/S announced that the Board of Directors proposes that dividends in the total amount of DKK 15 million be paid out of the net profit for the year 2012/2013, corresponding to 31% of the consolidated results for the year, whereas the remaining part of the net profit be carried forward to next year. The Board of Directors thus proposes that dividends in the amount of DKK 1.25 for each share of DKK 10.00 be distributed. For the fiscal year 2011/2012 the Company paid a dividend of DKK 3 per share.  Full Article

Ambu A/S Comments on FY 2013/2014 Financial Guidance and Issues Four-Year Financial Targets
Thursday, 14 Nov 2013 01:59am EST 

Ambu A/S announced that in the fiscal year 2012/2014 the Company expects organic growth of approximately 5-7% in Danish kroner, and revenue of approximately DKK 1.6 billion. EBIT margin for the fiscal year 2013 is expected to be of approximately 12-14%. Ambu also communicated that the Company launches new four-year strategy, Climbing New Heights, and is setting new financial targets for the period up until fiscal year 2017. According to the four-year strategy revenue is expected to be in the region of DKK 2 billion, and EBIT margin in the region of 17-18%. Working capital to revenue ratio is expected to be of approximately 20-25%.  Full Article

Ambu A/S' aScope 3 Gets FDA Market Clearance
Wednesday, 6 Nov 2013 03:56am EST 

Ambu A/S announced that the Company's single-use videoscope – aScope 3 – has received market clearance from the U.S. Food and Drug Administration (FDA) for sale in the United States (US). This means that Ambu will launch aScope 3 in the US at the beginning of 2014. aScope 3 was launched in Europe in May 2013.  Full Article

BRIEF-Ambu Q2 EBIT slightly up at DKK 48 million; outlook adjusted

* Q2 2014/15 revenue 483 million Danish crowns ($72.78 million) versus 403 million crowns year ago

Search Stocks